₩9,750.00 ($7.26)

+50.00 (+0.52%)

Weekly Expected Move ±2.4%

₩9276 ₩9513 ₩9750 ₩9987 ₩10224

KOE · Healthcare · Medical - Specialties · Tech Score Neutral · Power 46 · ₩211.7B mcap · 12M float · 0.377% daily turnover

Revenue

$162.0B +17.3% ▲

5Y CAGR: +2.4%

Gross Profit

$96.0B +17.3% ▲

5Y CAGR: +0.1%

Operating Income

$28.9B +10.7% ▲

5Y CAGR: -15.2%

Net Income

$23.7B -13.1% ▼

5Y CAGR: -12.2%

EPS (Diluted)

$1092.00 -12.1% ▼

5Y CAGR: -11.2%

EBITDA

$28.9B -29.7% ▼

5Y CAGR: -15.2%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$157.7B	$118.1B	$134.2B	$138.2B	$162.0B
YoY Growth	+9.4%	-25.1%	+13.7%	+2.9%	+17.3%
Cost of Revenue	$61.7B	$50.7B	$53.7B	$56.4B	$66.0B
Gross Profit	$96.0B	$67.4B	$80.5B	$81.8B	$96.0B
Gross Margin	60.9%	57.1%	60.0%	59.2%	59.2%
R&D Expenses	$14.3B	$14.7B	$13.4B	$16.0B	$0
SG&A Expenses	$28.9B	$27.0B	$33.6B	$14.2B	$67.0B
Operating Expenses	$45.4B	$44.1B	$47.1B	$55.6B	$67.0B
Operating Income	$51.9B	$23.3B	$33.4B	$26.2B	$28.9B
Operating Margin	32.9%	19.7%	24.9%	18.9%	17.9%
Interest Expense	$197M	$204M	$350M	$353M	$4.3B
Income Before Tax	$56.0B	$27.0B	$31.6B	$32.4B	$27.8B
Tax Expense	$8.6B	$1.7B	$4.9B	$5.2B	$3.9B
Net Income	$44.4B	$24.2B	$25.9B	$27.3B	$23.7B
Net Margin	28.1%	20.5%	19.3%	19.7%	14.6%
EPS (Diluted)	$1936.26	$1079.94	$1181.10	$1242.40	$1092.00
EBITDA	$62.7B	$35.0B	$40.2B	$41.2B	$28.9B
Shares Outstanding	23M	22M	22M	22M	22M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$37.6B	$31.2B	$39.1B	$41.5B	$39.9B	$41.5B	$42.8B	$50.4B
Cost of Revenue	$14.5B	$14.9B	$15.1B	$17.6B	$17.0B	$16.4B	$17.8B	$20.9B
Gross Profit	$23.1B	$16.3B	$24.0B	$23.9B	$23.0B	$25.1B	$25.0B	$29.5B
Gross Margin	61.5%	52.2%	61.4%	57.7%	57.5%	60.4%	58.4%	58.6%
R&D Expenses	$3.9B	$4.6B	$4.4B	$4.6B	$4.7B	$4.9B	$5.5B	$5.9B
SG&A Expenses	$3.6B	$3.5B	$4.8B	$4.6B	$6.1B	$4.7B	$5.0B	$6.4B
Operating Expenses	$14.3B	$14.2B	$15.9B	$14.7B	$16.3B	$18.1B	$18.2B	$21.3B
Operating Income	$8.8B	$2.2B	$8.1B	$9.2B	$6.6B	$5.1B	$6.8B	$8.2B
Operating Margin	23.5%	6.9%	20.7%	22.2%	16.5%	12.2%	15.9%	16.3%
Interest Expense	$177M	$80M	$84M	$88M	$83M	$4.1B	$167M	$160M
Income Before Tax	$7.4B	$5.4B	$8.7B	$8.6B	$9.6B	$854M	$12.0B	$9.5B
Tax Expense	$1.4B	$580M	$1.4B	$1.1B	$1.8B	-$504M	$2.5B	$1.9B
Net Income	$6.1B	$4.8B	$7.3B	$7.3B	$7.8B	$1.3B	$9.6B	$7.3B
Net Margin	16.2%	15.5%	18.5%	17.7%	19.5%	3.1%	22.4%	14.5%
EPS (Diluted)	$278.00	$222.20	$333.00	$337.12	$359.00	$62.71	$466.30	$336.00
EBITDA	$9.8B	$8.0B	$10.4B	$26.6B	$9.1B	-$7.8B	$14.6B	$12.2B
Shares Outstanding	22M	22M	22M	22M	22M	21M	21M	22M

206640.KQ KOE